Google-owned machine learning specialist DeepMind, responsible for the company's recent wins in the Go-bot arena, has announced a partnership with Moorfields Eye Hospital in London to analyse a cache of NHS eye scan data.
Best known for the AlphaGo artificial intelligence which has proven victorious in matches against human experts, DeepMind's machine learning technology is now being focused upon eye test data with the hope that it could lead to earlier spotting of serious conditions including age-related macular degeneration and other issues that afflict two million people in the UK alone.
'Our research with DeepMind has the potential to revolutionise the way professionals carry out eye tests and could lead to earlier detection and treatment of common eye diseases such as age-related macular degeneration,' claimed Professor Sir Peng Tee Khaw, director of the National Institute for Health Research Specialist Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, a man who likely requires foot-long business cards. 'With sight loss predicted to double by the year 2050 it is vital we explore the use of cutting-edge technology to prevent eye disease.'
The partnership between Moorfields Eye Hospital, an NHS Foundation Trust based in London, and DeepMind aims to use machine learning algorithms to detect and segment eye scan data, with the hope that it could aid with the early detection of diabetic retinopathy and age-related macular degeneration. To this end, DeepMind has been granted access to a database of eye-scan images, which the NHS Trust has anonymised.
More information is available on the official website.
Best known for the AlphaGo artificial intelligence which has proven victorious in matches against human experts, DeepMind's machine learning technology is now being focused upon eye test data with the hope that it could lead to earlier spotting of serious conditions including age-related macular degeneration and other issues that afflict two million people in the UK alone.
'Our research with DeepMind has the potential to revolutionise the way professionals carry out eye tests and could lead to earlier detection and treatment of common eye diseases such as age-related macular degeneration,' claimed Professor Sir Peng Tee Khaw, director of the National Institute for Health Research Specialist Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, a man who likely requires foot-long business cards. 'With sight loss predicted to double by the year 2050 it is vital we explore the use of cutting-edge technology to prevent eye disease.'
The partnership between Moorfields Eye Hospital, an NHS Foundation Trust based in London, and DeepMind aims to use machine learning algorithms to detect and segment eye scan data, with the hope that it could aid with the early detection of diabetic retinopathy and age-related macular degeneration. To this end, DeepMind has been granted access to a database of eye-scan images, which the NHS Trust has anonymised.
More information is available on the official website.
MSI MPG Velox 100R Chassis Review
October 14 2021 | 15:04
Want to comment? Please log in.